Следене
Mohamed Ramadan Mohamed
Mohamed Ramadan Mohamed
Потвърден имейл адрес: ukaachen.de
Заглавие
Позовавания
Позовавания
Година
Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease
MM Woitok, ME Zoubek, D Doleschel, M Bartneck, MR Mohamed, ...
Cell Death & Disease 11 (5), 343, 2020
382020
Loss of c‐Jun N‐terminal Kinase 1 and 2 function in liver epithelial cells triggers biliary hyperproliferation resembling cholangiocarcinoma
FJ Cubero, MR Mohamed, MM Woitok, G Zhao, M Hatting, YA Nevzorova, ...
Hepatology communications 4 (6), 834-851, 2020
302020
Alleviation of Dimethylnitrosamine-Induced Liver Injury and Fibrosis by Supplementation of Anabasis articulata Extract in Rats
AM Mohamed, MS Abdalla, MZ Rizk, ESME Mahdy, ARH Farrag, ...
Indian Journal of Clinical Biochemistry 29, 418-429, 2014
142014
Targeting ligand independent tropism of siRNA‐LNP by small molecules for directed therapy of liver or myeloid immune cells
C Lin, A Jans, JC Wolters, MR Mohamed, EPC Van der Vorst, C Trautwein, ...
Advanced healthcare materials 13 (26), 2202670, 2024
112024
Woitok MM, Zhao G, Hatting M, Nevzorova YA, et al
FJ Cubero, MR Mohamed
Loss of c-Jun N-terminal kinase 1, 0
6
JNKs protect from cholestatic liver disease progression by modulating Apelin signalling
MR Mohamed, J Haybaeck, H Wu, H Su, M Bartneck, C Lin, ...
JHEP Reports 5 (11), 100854, 2023
52023
Long‐term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals
H Su, M Haque, S Becker, K Edlund, J Duda, Q Wang, J Reißing, ...
Liver International 43 (8), 1699-1713, 2023
42023
Activation of the unfolded protein response (UPR) is associated with Cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of Fibropolycystic liver disease
C Chen, H Wu, H Ye, A Tortajada, S Rodríguez-Perales, R Torres-Ruiz, ...
Cancers 14 (1), 78, 2021
32021
Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression
I Volkert, M Fromme, C Schneider, L Candels, C Lindhauer, H Su, ...
Hepatology 79 (4), 898-911, 2024
22024
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
K Zheng, F Hao, S Medrano-Garcia, C Chen, F Guo, L Morán-Blanco, ...
Cell death & disease 14 (8), 514, 2023
12023
Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
A Lamas-Paz, A Hionides-Gutiérrez, F Guo, G Jorquera, L Morán-Blanco, ...
JHEP Reports 7 (1), 101230, 2025
2025
Der Einfluss des PNPLA3 I148M-Polymorphismus auf das Fortschreiten einer Lebererkrankung bei schwerem Alpha1-Antitrypsin-Mangel
I Volkert, M Fromme, C Schneider, H Su, M Mohamed, C Lindhauer, ...
Zeitschrift für Gastroenterologie 61 (08), KV103, 2023
2023
PNPLA3 I148M substitution excerbate NAFLD under a long-term high fat diet
H Su, M Haque, S Becker, K Edlund, J Duda, Q Wang, J Reißing, ...
Journal of Hepatology 78, S778, 2023
2023
PNPLA3 I148M polymorphism does not promote liver disease progression in severe alpha1-antitrypsin deficiency
I Volkert, M Fromme, H Su, N Gueldiken, MR Mohamed, C Lindhauer, ...
Journal of Hepatology 78, S639, 2023
2023
JNKs protect from cholestatic liver disease progression by modulating Apelin signalling
M Ramadan Mohamed, H Wu, FJ Cubero Palero, C Trautwein
2023
PNPLA3 I148M polymorphism aggravate metabolic liver disease under Long-term high fat diet
C Trautwein, H Su, M Haque, S Becker, K Edlund, J Duda, Q Wang, ...
Zeitschrift für Gastroenterologie 61 (01), P3. 25, 2023
2023
Activation of the unfolded protein response (UPR) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease
MU Latasa, R Bañares, C Berasain, M Arechederra, ...
2022
Activation of the unfolded protein response (UPR) and fibrosis is associated withcholangiocellular injury in an experimental model of fibropolycystic liver disease
H Wu, C Chen, H Ye, A Tortajada, S Rodríguez-Perales, R Torres-Ruiz, ...
Zeitschrift für Gastroenterologie 60 (01), P 1.03, 2022
2022
Cell-type-specific function of c-Jun N-terminal kinases (JNKs) determines the cholestasis activity in murine model
MR Mohamed, G Zhao, YA Nevzorova, J Haybaeck, MV Boekschoten, ...
Zeitschrift für Gastroenterologie 59 (08), A 154, 2021
2021
JNK mediates differential protection in hepatocytes and non-parenchymal cells during cholestasis
MR Mohamed, G Zhao, YA Nevzorova, J Haybaeck, MV Boekschoten, ...
Zeitschrift für Gastroenterologie 59 (01), 1.4, 2021
2021
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20